BioHarvest Sciences Inc.
BHST
$6.71
-$0.09-1.32%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 20.91% | -9.93% | -291.41% | 89.56% | 9.04% |
| Total Depreciation and Amortization | 17.01% | -2.85% | -1.68% | 76.73% | -6.48% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -17.19% | 0.33% | 162.04% | -118.35% | 22.50% |
| Change in Net Operating Assets | 102.90% | -1,479.17% | -106.98% | 169.35% | -65.89% |
| Cash from Operations | 40.27% | -35.82% | -83.61% | 39.29% | 47.29% |
| Capital Expenditure | -74.05% | 23.24% | 70.02% | -669.37% | 23.71% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 157.14% | -117.50% | 117.78% | -- | -- |
| Cash from Investing | -70.00% | 15.25% | 75.58% | -770.72% | 23.71% |
| Total Debt Issued | 0.88% | -- | -- | -- | -- |
| Total Debt Repaid | 74.30% | -424.39% | -37.82% | 7.75% | -43.33% |
| Issuance of Common Stock | -- | -- | -100.00% | 36,246.15% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 27.22% | 1,596.34% | -103.56% | 4,070.69% | -101.66% |
| Foreign Exchange rate Adjustments | 90.70% | -760.00% | -129.41% | 666.67% | -104.17% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 367.46% | 84.25% | -238.57% | 190.26% | -150.55% |